Cargando…
Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status
In heart failure (HF) with reduced ejection fraction (HFrEF), four classes of drugs (β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor neprilysin inhibitors, mineralocorticoid receptor antagonists, and the most recent Sodium–Glucose Co-Transporters 2 Inhibitors) have demonstr...
Autores principales: | Paraskevaidis, Ioannis, Xanthopoulos, Andrew, Karamichalakis, Nikolaos, Triposkiadis, Filippos, Tsougos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302950/ https://www.ncbi.nlm.nih.gov/pubmed/37367737 http://dx.doi.org/10.3390/medsci11020038 |
Ejemplares similares
-
Reshaping Treatment of Heart Failure with Preserved Ejection Fraction
por: Karamichalakis, Nikolaos, et al.
Publicado: (2022) -
Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023) -
Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022) -
A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation
por: Karamichalakis, Nikolaos, et al.
Publicado: (2022) -
Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)